Le Lézard
Classified in: Health
Subjects: MAV, AWD, CHI, EXE

/R E P E A T -- Notice to the media - Minister of Health to celebrate winners of national recipe contest/



OTTAWA, Oct. 20, 2017 /CNW/ - The Honourable Ginette Petitpas Taylor, Minister of Health, will deliver remarks at the Kid Food Nation Gala and present awards to the winners of the national recipe contest.

The Minister will be available to answer questions from the media following her remarks.

Date
October 22, 2017

Time
Remarks: 12:05 pm EDT
Media Availability: 1:15 pm EDT

Location
Fairmont Chateau Laurier
Drawing Room
1 Rideau Street
Ottawa, ON

 

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 01:00
Midazolam Nasal Spray (USL261), is a nasally administered investigational midazolam formulation intended as a rescue treatment of acute repetitive seizures (ARS) in patients with epilepsy, which has completed Phase 3 clinical development and is ready...

at 00:32
Top 6 Digital Enterprises, a Pennsylvania-based digital arbitrage shop, focuses on delivering high-quality leads to online advertisers. Through forward-thinking strategies, Top6Digital is able to acquire highly motivated customers at below-market...

at 00:00
DALLAS, Apr. 20, 2018 /PRNewswire-PRWeb/ -- Dallas rhinoplasty specialist and meeting chairman, Dr. Rod J. Rohrich, recently hosted the 35th annual Dallas Rhinoplasty Meeting at the Westin Galleria in Dallas, Texas. The two day event, which is...

19 avr 2018
NY State Senator Michael Gianaris (D-12) joined Goodwill Industries of Greater New York and Northern NJ, Inc. (Goodwill NYNJ) to celebrate the talents and career accomplishments of more than 60 individuals with autism who have secured competitive...

19 avr 2018
U.S. District Judge Kristine G. Baker for the Eastern District of Arkansas entered a consent decree of permanent injunction today between the U.S. and Cantrell Drug Company of Little Rock, Arkansas, and the company's Chief Executive Officer and...

19 avr 2018
ESSA Pharma Inc. ("ESSA" or the "Company") , a pre-clinical stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, is pleased to announce that on April 18, 2018 the board of directors of the Company...




News published on 22 october 2017 at 06:00 and distributed by: